Cargando…
Intra-Arterial Infusion Chemotherapy in Advanced Pancreatic Cancer: A Comprehensive Review
SIMPLE SUMMARY: Pancreatic cancer has a very poor prognosis. The few available therapeutic options are characterized by low efficacy and high toxicity due to the intrinsic chemoresistance of this tumor type. To improve clinical results, some clinical trials have evaluated regional chemotherapy as a...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774130/ https://www.ncbi.nlm.nih.gov/pubmed/35053614 http://dx.doi.org/10.3390/cancers14020450 |
_version_ | 1784636262598049792 |
---|---|
author | Laface, Carmelo Laforgia, Mariarita Molinari, Pasquale Foti, Caterina Ambrogio, Francesca Gadaleta, Cosmo Damiano Ranieri, Girolamo |
author_facet | Laface, Carmelo Laforgia, Mariarita Molinari, Pasquale Foti, Caterina Ambrogio, Francesca Gadaleta, Cosmo Damiano Ranieri, Girolamo |
author_sort | Laface, Carmelo |
collection | PubMed |
description | SIMPLE SUMMARY: Pancreatic cancer has a very poor prognosis. The few available therapeutic options are characterized by low efficacy and high toxicity due to the intrinsic chemoresistance of this tumor type. To improve clinical results, some clinical trials have evaluated regional chemotherapy as a treatment option for PC. The pancreatic arterial infusion of chemotherapeutics has the aim of obtaining higher local concentrations of drugs and, at the same time, of limiting systemic toxicity. This therapeutic approach has already been successfully evaluated for the treatment of several types of tumors. Regarding advanced pancreatic cancers, only a few clinical studies have investigated the safety and efficacy of this treatment, with very promising results. Therefore, in this review, we summarize literature data on the clinical approaches to pancreatic arterial drug administration for the treatment of advanced PC to deepen knowledge on this topic. ABSTRACT: Advanced pancreatic cancer (PC) has a very poor prognosis due to its chemoresistant nature. Nowadays, only a few therapeutic options are available for PC, and the most effective ones are characterized by low response rates (RRs), short progression-free survival and overall survival, and severe toxicity. To improve clinical results, small series studies have evaluated loco-regional chemotherapy as a treatment option for PC, demonstrating its dose-dependent sensitivity towards the tumor. In fact, pancreatic arterial infusion (PAI) chemotherapy allows higher local concentrations of chemotherapeutic agents, sparing healthy tissues with a lower rate of adverse events compared to systemic chemotherapy. This therapeutic approach has already been evaluated in different types of tumors, especially in primary and metastatic liver cancers, with favourable results. With regard to advanced PC, a few clinical studies have investigated the safety and efficacy of PAI with promising results, especially in terms of RRs compared to systemic chemotherapy. However, clear evidence about its efficacy has not been established yet nor have the underlying mechanisms leading to its success. In this review, we aim to summarize the literature data on the clinical approaches to pancreatic arterial drug administration in terms of techniques, drug pharmacokinetics, and clinical outcomes for advanced PC. |
format | Online Article Text |
id | pubmed-8774130 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87741302022-01-21 Intra-Arterial Infusion Chemotherapy in Advanced Pancreatic Cancer: A Comprehensive Review Laface, Carmelo Laforgia, Mariarita Molinari, Pasquale Foti, Caterina Ambrogio, Francesca Gadaleta, Cosmo Damiano Ranieri, Girolamo Cancers (Basel) Review SIMPLE SUMMARY: Pancreatic cancer has a very poor prognosis. The few available therapeutic options are characterized by low efficacy and high toxicity due to the intrinsic chemoresistance of this tumor type. To improve clinical results, some clinical trials have evaluated regional chemotherapy as a treatment option for PC. The pancreatic arterial infusion of chemotherapeutics has the aim of obtaining higher local concentrations of drugs and, at the same time, of limiting systemic toxicity. This therapeutic approach has already been successfully evaluated for the treatment of several types of tumors. Regarding advanced pancreatic cancers, only a few clinical studies have investigated the safety and efficacy of this treatment, with very promising results. Therefore, in this review, we summarize literature data on the clinical approaches to pancreatic arterial drug administration for the treatment of advanced PC to deepen knowledge on this topic. ABSTRACT: Advanced pancreatic cancer (PC) has a very poor prognosis due to its chemoresistant nature. Nowadays, only a few therapeutic options are available for PC, and the most effective ones are characterized by low response rates (RRs), short progression-free survival and overall survival, and severe toxicity. To improve clinical results, small series studies have evaluated loco-regional chemotherapy as a treatment option for PC, demonstrating its dose-dependent sensitivity towards the tumor. In fact, pancreatic arterial infusion (PAI) chemotherapy allows higher local concentrations of chemotherapeutic agents, sparing healthy tissues with a lower rate of adverse events compared to systemic chemotherapy. This therapeutic approach has already been evaluated in different types of tumors, especially in primary and metastatic liver cancers, with favourable results. With regard to advanced PC, a few clinical studies have investigated the safety and efficacy of PAI with promising results, especially in terms of RRs compared to systemic chemotherapy. However, clear evidence about its efficacy has not been established yet nor have the underlying mechanisms leading to its success. In this review, we aim to summarize the literature data on the clinical approaches to pancreatic arterial drug administration in terms of techniques, drug pharmacokinetics, and clinical outcomes for advanced PC. MDPI 2022-01-17 /pmc/articles/PMC8774130/ /pubmed/35053614 http://dx.doi.org/10.3390/cancers14020450 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Laface, Carmelo Laforgia, Mariarita Molinari, Pasquale Foti, Caterina Ambrogio, Francesca Gadaleta, Cosmo Damiano Ranieri, Girolamo Intra-Arterial Infusion Chemotherapy in Advanced Pancreatic Cancer: A Comprehensive Review |
title | Intra-Arterial Infusion Chemotherapy in Advanced Pancreatic Cancer: A Comprehensive Review |
title_full | Intra-Arterial Infusion Chemotherapy in Advanced Pancreatic Cancer: A Comprehensive Review |
title_fullStr | Intra-Arterial Infusion Chemotherapy in Advanced Pancreatic Cancer: A Comprehensive Review |
title_full_unstemmed | Intra-Arterial Infusion Chemotherapy in Advanced Pancreatic Cancer: A Comprehensive Review |
title_short | Intra-Arterial Infusion Chemotherapy in Advanced Pancreatic Cancer: A Comprehensive Review |
title_sort | intra-arterial infusion chemotherapy in advanced pancreatic cancer: a comprehensive review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774130/ https://www.ncbi.nlm.nih.gov/pubmed/35053614 http://dx.doi.org/10.3390/cancers14020450 |
work_keys_str_mv | AT lafacecarmelo intraarterialinfusionchemotherapyinadvancedpancreaticcanceracomprehensivereview AT laforgiamariarita intraarterialinfusionchemotherapyinadvancedpancreaticcanceracomprehensivereview AT molinaripasquale intraarterialinfusionchemotherapyinadvancedpancreaticcanceracomprehensivereview AT foticaterina intraarterialinfusionchemotherapyinadvancedpancreaticcanceracomprehensivereview AT ambrogiofrancesca intraarterialinfusionchemotherapyinadvancedpancreaticcanceracomprehensivereview AT gadaletacosmodamiano intraarterialinfusionchemotherapyinadvancedpancreaticcanceracomprehensivereview AT ranierigirolamo intraarterialinfusionchemotherapyinadvancedpancreaticcanceracomprehensivereview |